Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Bone Marrow Transplant. 2023 Feb;58(2):222-225. doi: 10.1038/s41409-022-01870-9. Epub 2022 Nov 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Myelodysplastic Syndromes* / therapy
  • Neoplasms*
  • Retrospective Studies
  • Transplantation Conditioning